Nov 26, 2024

Public workspaceImmunofluorescent labelling of paraffin brain tissue sections

Peer-reviewed method
  • 1Department Anatomy and Medical Imaging, The University of Auckland;
  • 2Centre for Brain Research, The University of Auckland
  • PLOS ONE Lab Protocols
    Tech. support email: plosone@plos.org
Icon indicating open access to content
QR code linking to this content
Protocol CitationBirger Victor Dieriks, Helen Murray 2024. Immunofluorescent labelling of paraffin brain tissue sections. protocols.io https://dx.doi.org/10.17504/protocols.io.5qpvo3wdzv4o/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: December 08, 2023
Last Modified: November 26, 2024
Protocol Integer ID: 91988
Keywords: Paraffin Immunohistochemistry, IHC labelling protocol, immunofluorescence protocol, labelling brain sections, immunohistochemistry
Funders Acknowledgements:
Health Research Council Hercus Fellowship
Grant ID: 21/034
Royal Society of New Zealand Te Apārangi - Catalyst Seeding
Grant ID: 22-UOA-049-CSG
Neurological Foundation of New Zealand
Grant ID: 2026 PRG
Health Ed Trust
Grant ID: Postdoctoral Fellowship
Health Research Council of New Zealand Emerging Researcher First Grant
Grant ID: 21/646
Health Research Council of New Zealand Programme Grant
Grant ID: 21/710
Abstract
This immunofluorescence protocol permits the labelling of multiple antibodies on one paraffin tissue section. This protocol details the potential variations that detect the protein of interest using fluorescently labelled secondary antibodies.
Immunohistochemistry (IHC) combines anatomical, immunological and biochemical techniques to image discrete tissue components by using appropriately labelled antibodies to bind specifically to their target antigens in situ. IHC makes it possible to visualize and document the high-resolution distribution and localization of specific cellular components within cells and their proper histological context. There are multiple approaches and permutations in IHC methodology. 

Figure 1. Different approaches for IHC (image by Dr Helen Murray and Dr Victor Dieriks)
Immunofluorescence permits labelling of multiple antibodies on one tissue section. For double or triple labelling, the primary antibodies must be raised in different species e.g. mouse, rabbit, chicken, guinea pig or goat. The corresponding secondary antibodies are conjugated to fluorophores with non-overlapping excitation/emission spectra (commonly used are fluorophores that excite at 488, 594 and 647nm). Antibodies from the same species but different Ig subtypes (e.g. mouse IgG1, IgG2a, IgG2b, IgG3, IgM) can be combined only if secondary antibodies that are highly specific to these subtypes are used. The specific excitation and emission wavelengths of different fluorophores permits labelling of multiple antibodies on one tissue section and visualisation of the labelling using widefield fluorescence or confocal microscopy. Hoechst or DAPI are commonly used nuclear counterstains for immunofluorescence.
 
Amplified IHC methods include fluorescent tyramide signal amplification (TSA, Figure 1e) and chromogenic 3,3′-Diaminobenzidine (DAB, Figure 1f) labelling. These methods detect the primary antibody using a secondary antibody conjugated to the horse-radish peroxidase (HRP) enzyme (Figure 2a). Alternatively, a biotin-conjugated secondary antibody can be applied, followed by a streptavidin conjugated HRP (Figure 2b). For chromogenic labelling, HRP converts the soluble substrate DAB into an insoluble brown product that can be visualised using brightfield microscopy. For fluorescence labelling, HRP converts an inactive tyramide-fluorophore complex into an active fluorescent complex that can be visualized using fluorescence microscopy.

Figure 2. Different permutations of amplified IHC (image by Dr Helen Murray and Dr Victor Dieriks)
Counterstains Nissl is a common nuclear counterstain for chromogenic labelling. Hoechst or DAPI are common fluorescent dyes used to stain DNA for fluorescent counterstaining.
Guidelines
Heat block reaches 60° Celcius and can cause burns when skin comes into contact with the hot surface.
Materials
Statmark Permanent marking pen - alcohol and solvent-resistant (Statlab)

Antigen retrieval buffers
Sodium citrate buffer (Concentration10 millimolar (mM) Sodium citrate, Concentration0.05 % (v/v) Tween 20, pH 6.0)
  • Tri-sodium citrate (dihydrate) 2.94 g.
  • Distilled water 1 L.
  • Mix to dissolve. Adjust to Ph6 with 1N HCl.
  • Add 0.5 mL Tween 20 and mix well. Store at room temperature for three months or at Temperature4 °C for more extended storage.

Tris-EDTA buffer (Concentration10 millimolar (mM) Tris base, 1 mM EDTA solution,Concentration0.05 % (v/v) Tween 20, pH 9.0)
  • Tris 1.21 g.
  • EDTA 0.37 g.
  • Distilled water 1 L.
  • Mix to dissolve. Adjust pH to Ph9 .
  • Add 0.5 mL Tween 20 and mix well. Store at room temperature for three months or at Temperature4 °C for more extended storage.

Buffers can be used without detergent if your antibody labelling is sensitive to detergent.
Sodium citrate buffer (Concentration10 millimolar (mM) Sodium citrate, Concentration0.05 % (v/v) without Tween 20, pH 6.0)
  • Tri-sodium citrate (dihydrate) 2.94 g.
  • Distilled water 1 L.
  • Mix to dissolve. Adjust to Ph6 with 1N HCl.
  • Store at room temperature for three months or at Temperature4 °C for more extended storage.

Tris-EDTA buffer (Concentration10 millimolar (mM) Tris base, 1 mM EDTA solution,Concentration0.05 % (v/v) without Tween 20, pH 9.0)
  • Tris 1.21 g.
  • EDTA 0.37 g.
  • Distilled water 1 L.
  • Mix to dissolve. Adjust pH to Ph9 .
  • Store at room temperature for three months or at Temperature4 °C for more extended storage.

ImmEdge Pen (Vector Laboratories, cat H-4000)
TrueBlack (Biotum, cat 23007)

dH20
PBS
NGS
NDS
triton-x100
tween 20
Hoechst
an intermediate dilution for Hoechst can be made and stored for up to one year. Dilute Hoechst 1:500 in H2O. DO NOT USE PBS for this step, as Hoechst is unstable in phosphate buffers.

add full antibody list here MAYBE INCLUDE COMMONLY USED PRIMARIES
ABCDEFG
AntibodyTargetSpeciesIsotypeManufacturerCatalogue No.Dilution
Goat anti-mouse AlexaFluor 488MouseGoatIgG (H+L)ThermoFisher A110011:500
Goat anti-mouse AlexaFluor 488MouseGoatIgG1ThermoFisher A211211:500
Goat anti-mouse AlexaFluor 488MouseGoatIgG2aThermoFisher A211311:500
Goat anti-rabbit AlexaFluor 488RabbitGoatIgG (H+L)ThermoFisher A110341:500
Goat anti-chicken AlexaFluor 488ChickenGoatIgG (H+L)ThermoFisher A110391:500
Goat anti-mouse AlexaFluor 594MouseGoatIgG (H+L)ThermoFisher A110321:500
Goat anti-mouse AlexaFluor 594MouseGoatIgG1ThermoFisher A211251:500
Goat anti-mouse AlexaFluor 594MouseGoatIgG2aThermoFisher A211351:500
Goat anti-rabbit AlexaFluor 594RabbitGoatIgG (H+L)ThermoFisher A110371:500
Goat anti-chicken AlexaFluor 594ChickenGoatIgG (H+L)ThermoFisher A214491:500
Goat anti-mouse AlexaFluor 647MouseGoatIgG2cJackson ImmunoResearch 115-607-1881:500
Goat anti-guinea pig AlexaFluor 647Guinea PigGoatIgG (H+L)ThermoFisher A214501:500
Goat anti-rabbit AlexaFluor 647RabbitGoatIgG (H+L)ThermoFisher A212451:500
Goat anti-chicken AlexaFluor 647ChickenGoatIgG (H+L)ThermoFisher A214491:500
Goat anti-rabbit AlexaFluor 800RabbitGoatIgG (H+L) LI-COR 926-322111:500
Donkey anti-goat AlexaFluor 647GoatDonkeyIgG (H+L)ThermoFisher A214471:500

Safety warnings
Heat block reaches 60° Celcius and can cause burns when skin comes into contact with the hot surface.
When using acids work in the fume cabinet avoiding spills and skin contact.
Make sure chemical waste is disposed of according to on-site regulations.
Ethics statement
The human post-mortem brain tissue used in this project was sourced from the Neurological Foundation Human Brain Bank (Centre for Brain Research, University of Auckland, New Zealand). All brain tissue was donated upon written, informed consent from the individual(s) and/or next of kin before brain removal.
Please ensure consent is obtained, and all protocols required used are approved by the relevant Ethics Committee.
Slide preparation
Slide preparation
Label slides with a Statmark pen or a pencil.
Note
Any other ink will wash off during dewaxing in step 3
Always include the proper controls for any fluorescent labelling. Control sections where the primary antibody was omitted should show no immunoreactivity.
Formalin-fixed paraffin-embedded tissue sections, when mounted on glass slides for microscopic examination, are placed on a hotplate with the tissue side up. This practice serves to

  • Facilitate Tissue Adherence: The hotplate softens the paraffin, allowing the tissue to flatten and firmly adhere to the glass slide. This ensures the tissue's integrity and correct orientation during staining and microscopic analysis.
  • Effectively Dehydrate: Paraffin sections often retain residual water. The hotplate aids in the removal of this water by evaporation, ensuring proper dehydration. Adequate dehydration is critical for subsequent staining and the preservation of tissue structures.
  • Place all slides on a hot plate (Leica HI1220) at Temperature60 °C for up to Duration01:00:00
Note
This step cooks the Statmark ink to the slide and melts the wax. Duration01:00:00 is the maximum; 20 minutes is sufficient if you are pushed for time.





1h
Dewaxing
Dewaxing
1h 20m
1h 20m
Immediately following hotplate incubation, sections were submerged in
Duration00:30:00 2 x 100% xylene baths to remove paraffin wax.
Subsequently, tissue sections were rehydrated by submerging slides in a series of alcohol baths
Duration00:15:00 2 x 100% EtOH
Duration00:05:00 95% EtOH
Duration00:05:00 80% EtOH
Duration00:05:00 75% EtOH
Duration00:05:00 3 x distilled H2O (dH2O) to wash off any remaining EtOH. 



1h 5m
Antigen retrieval in pressure cooker
Antigen retrieval in pressure cooker
1h 40m
1h 40m
Fill the pressure Cooker with approx. 600ml dH2O.

Add slides in the cassette holder. Add the antigen retrieval buffer to the pressure cooker cartridge (Biovendor). Make sure to add sufficient antigen retrieval buffer to cover the tissue, but not to overfill
Frequently used buffers:
  • Sodium citrate buffer pH6
  • Tris-EDTA buffer pH9

Note
The antigen retrieval buffer depends on the antibodies you are using. This needs to be optimised by testing the various options.




Press start.
This will initiate a heating protocol where the pressure cooker reaches Temperature121 °C at 1 bar for Duration00:20:00 , followed by an Duration01:40:00 of gradual cool down.


Note
Cassettes with slides can be left in the pressure cooker after 20 min heating or taken out and placed at room temperature. This will not affect the staining.



2h
Pour out the antigen retrieval solution and replace it with 1x dH2O. Repeat 2x for about Duration00:05:00 per wash.
Use the pressure cooker cartridges for the wash steps in the rest of the protocol.
5m
Go togo to step #7 if no additional antigen retrieval is required.

**OPTIONAL** Formic Acid Antigen retrieval
**OPTIONAL** Formic Acid Antigen retrieval
Embedding tissue in paraffin often leads to the masking of antigenic sites due to the formation of cross-links between proteins, which can hinder the binding of antibodies to their target antigens. Formic acid, a strong acid, reverses this masking effect. It works by breaking down these protein cross-links, thus exposing the antigenic sites that were previously hidden. This additional formic acid antigen retrieval is especially beneficial for detecting certain types of antigens, such as prion proteins and other aggregated proteins, such as alpha-synuclein and Tau.
Optional
Tap dry slides and add 99% formic acid for Duration00:04:00 at TemperatureRoom temperature

Note
Formic acid is a strong acid and should be used and dispersed in a fume cabinet following the local Health and Safety requirements.

4m
Toxic
Wash immediately with dH20 3x Duration00:05:00 per wash.
5m
Go togo to step #7 if no additional antigen retrieval is required.
**OPTIONAL** Hydrochloric Acid Antigen retrieval
**OPTIONAL** Hydrochloric Acid Antigen retrieval
Hydrochloric Acid (HCl) antigen retrieval is particularly effective for visualizing nuclear antigens in paraffin-embedded tissue sections. By breaking down the protein cross-links that mask these antigens during formalin fixation, HCl enhances the exposure and binding of antibodies to nuclear epitopes, thus improving the clarity and specificity of immunohistochemical staining.
CITATION
Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M (2014). Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain..

Optional
Tap dry slides and add 2N HCL for Duration00:05:00 at TemperatureRoom temperature .

Note
Hydrochloric Acid is a strong acid and should be used and dispersed in a fume cabinet following the local Health and Safety requirements.



5m
Toxic
Wash immediately with dH20 3x Duration00:05:00 per wash.
5m
Go togo to step #10 if no additional antigen retrieval is required.
Wax borders
Wax borders
Draw a hydrophobic barrier around each tissue section to reduce the reagents required.

This step can be done during the 3 x dH2O washes


Note
The wax borders must be drawn before permeabilisation because the wax will not stick to the slide if it is coated in detergent.

Critical
Drain dH2O from the slides one slide at a time, but DO NOT let sections dry out. Draw a hydrophobic barrier around each tissue section using the ImmEdge pen (Vector Laboratories). To conserve reagents, draw barriers close to, but not on, sections. Tissue with a wax pen on top has high autofluorescence.
Place the slide back into dH2O until all slides are done.

Note
The ImmEdge pen draws a hydrophobic barrier around each tissue section, but sometimes an excess amount of liquid flows out of the pen. To avoid this, always test the pen on tissue paper when starting a new exp.
The wax may not bind well to some brands of glass slide if there is residual dH2O on the glass. Use a paper towel to dry the area of glass carefully where you want to draw the wax border, but be careful not to touch the tissue.
Exposing the wax border to water before it has adequately dried will result in it being compromised




Permeablisation
Permeablisation
Once wax borders are completed, replace dH2O with PBS-T and incubate for Duration00:15:00 at Temperature4 °C


Note
This step can be omitted if your antibody labelling is sensitive to detergent. This should be optimised for each antibody.

15m
Wash slides 3x Duration00:05:00 in 1x PBS.

5m
Go togo to step #10 if TrueBlack treatment is not required.
**OPTIONAL** TrueBlack autofluorescence quencher.
**OPTIONAL** TrueBlack autofluorescence quencher.
Trueblack treatment reduces the autofluorescence that is present in human brain sections. However, this additional step is only required when the signal-to-noise ratio of your labelling is low. TrueBlack can improve the signal for low-intensity labeling by reducing the background.
Optional
Wash sections 3x Duration00:05:00 in dH2O. PBS will cause the TrueBlack to clump on the tissue.
5m
Wash
Critical
Dilute TrueBlack (Biotum) reagent 1:20 in 70% EtOH (make 50µl per section depending on tissue size). Make sufficient true black solution to adequately cover the tissue section



Incubation
Place sections on a tray and add TrueBlack solution to sections for Duration00:00:30
Note
When adding a small amount of TrueBlack, a portion of the section can dry out. Therefore, we recommend placing the slides on a tray and swirling the slides gently to evenly distribute the Trueblack.

30s
Wash sections 3x Duration00:05:00 in dH2O. PBS will cause the TrueBlack to clump on the tissue.
5m
Wash
Critical
Wash sections 3x Duration00:05:00 in PBS.
5m
Blocking for non specific labelling
Blocking for non specific labelling
In this step, we will block potential non-specific labelling. Ideally, this is performed using serum from animals in which the secondary antibodies were made (eg. if using goat secondary antibodies, then use goat serum; if using donkey secondary antibodies, then donkey serum). In practice, both can be used. HOWEVER, when a primary goat antibody is used, one cannot use goat serum in this protocol, as the secondary anti-goat antibody would label the entire section as it is covered with goat serum.
Make a humidified slide chamber by adding wet paper towels to one of the plastic slide chambers or trays. You can also use this time to check if you need to make a 10% blocking buffer and defrost the serum from Temperature-20 °C freezer if needed.



Make a 10% serum-blocking solution
  • 500 µl serum stock solution + 4.5 ml 1x PBS. Use goat or donkey serum, depending on the species of your secondary antibodies. 10% serum solutions should be stored at Temperature4 °C and discarded after two weeks. 10% serum solutions can be stored at Temperature-20 °C and repeatedly freeze/thawed.

Drain excess PBS from slides and move to the humid chamber. Add 100-200 µl of 10% blocking solution to each slide. Ensure the tissue is completely covered to the wax border. The volume of serum needed depends on the size of the tissue and doesn't have to be precise. Tissue needs to be entirely covered.

Primary antibody incubation
Primary antibody incubation
For immunolabeling techniques like immunofluorescence, selecting the appropriate antibody is pivotal for the specificity and sensitivity of the assay. Antibodies serve as tools to specifically detect target antigens within a sample, and the precision of this detection largely hinges on the antibody's quality and specificity. The source of the antibody, marked by the supplier's reliability and reputation, plays a significant role since antibodies can differ substantially in their quality, purity, and overall performance based on their origin. Consequently, it is essential for researchers to meticulously assess their experimental needs and choose antibodies that align optimally with the requirements of their specific applications. This careful selection is key to ensuring the immunolabeling results are accurate.
Make immunobuffer: 1% normal goat (NGS) or donkey serum (NDS) in PBS
  • 1 ml 10% NGS (or NDS) from step 6 + 9 ml 1x PBS. 1% serum solutions should be stored at Temperature4 °C and discarded after two weeks. 1% serum solutions can be stored at Temperature-20 °C and repeatedly freeze/thawed.
Dilute antibodies in immunobuffer.
Dilution factors depend on the company, individual antibody and region of interest.
Note
For double or triple labelling, the primary antibodies must be raised in different species, e.g., mice, rabbits, chickens, guinea pigs, or goats. The corresponding secondary antibodies are conjugated to fluorophores with non-overlapping excitation/emission spectra (commonly used are fluorophores that excite at 488, 594 and 647nm). Antibodies from the same species but different Ig subtypes (e.g. mouse IgG1, IgG2a, IgG2b, IgG3, IgM) can be combined only if highly specific secondary antibodies to these subtypes are used.
Thaw/store antibodies on ice during the protocol. Once thawed vortex and centrifuge before taking the required amount.
Remove the 10% serum solution from the sections and return the slides to the humid chamber. No wash step is required here because the primary antibodies are diluted in the same serum.
Add 100-200 µl of antibody solution to each slide. Volume can be optimised in the blocking step.
Note
The entire section must be covered with the antibody solution, as any dried-out sections will have increased autofluorescence.

Pipetting
Critical
Incubate at Temperature4 °C overnight.

Note
As we use small volumes, sections can dry out during the overnight incubation. It is critical there is an excess amount of liquid in the humid chamber and it is well sealed.

Pipetting
Critical
Overnight
Washing off primary antibody dilution
Washing off primary antibody dilution
5m
5m
Antibody solution can be removed and discarded or recovered for additional antibody incubations. In our hands, we have successfully re-used primary antibody solutions up to three times. Store at Temperature-4 °C for up to two weeks or at Temperature-20 °C for long-term storage.
Remove the primary antibody solution and transfer the slides back to the pressure cooker cartridge for 3 x Duration00:05:00 washes with 1x PBS. 

5m
Go togo to step #10 if peroxidase blocking is not required.
VARIATION** Block endogenous peroxidases.
VARIATION** Block endogenous peroxidases.
15m
15m
This step is required for DAB labelling, Tyramide Signal Amplification (TSA) or any labelling that involves peroxidase-based signal amplification.

Optional
Make methanol blocking solution: 50% methanol + 1% H2O2 in MilliQ water

Incubate at TemperatureRoom temperature for Duration00:10:00

10m
Wash 3x Duration00:05:00 with 1x PBS and continue to the secondary antibody incubation step
5m
Secondary antibody incubation
Secondary antibody incubation
15m
15m
Secondary antibodies can be incubated
  • overnight at Temperature4 °C or
  • at TemperatureRoom temperature for Duration03:00:00

3h
Dilute secondary antibodies 1:500 in immunobuffer. Add Hoechst diluted at 1:20,000 If doing fluorescence labelling. Hoechst counterstaining does not interact with secondary binding, so it is more efficient to include it in this step.
Note
A 1:500 dilution is used for secondary antibodies, such as ThermoFisher, Jackson ImmunoResearch, and Santa Cruz. This dilution works well and we have found that changing secondary antibody dilution has minimal impact on the overall staining.

Transfer slides to the humid chamber and add ­­­­100-­200µl of secondary antibody solution to each slide
Incubate at TemperatureRoom temperature for Duration03:00:00 . Cover the slide chamber with tinfoil to protect fluorophores from light.

3h
Remove the secondary antibody solution.
Transfer the slides back to the pressure cooker cartridge for 3 x Duration00:05:00 washes with 1x PBS and continue to coverslipping
5m
VARIATION** Tyramide amplification
VARIATION** Tyramide amplification
15m
15m
We use Alexa Flour 488/594/647 Tyramide Superboost Kits (ThermoFisher) for primary antibody signal amplification. If additional secondary antibodies are simultaneously required, then these were diluted in 1x poly-HRP conjugated goat anti-mouse IgG secondary antibody (B40912-B, ThermoFisher) and added to the sections for Duration03:00:00 at TemperatureRoom temperature as described above.

Note
Poly-HRP conjugated goat anti-mouse IgG secondary antibody incubation can occur simultaneously with fluorescently conjugated secondaries from Go togo to step #14.1


Following incubation, the secondary antibody solutions were aspirated from slides and underwent 3 x Duration00:05:00 PBS washes.


3h 5m
Optional
Prepare Tyramide working solution by diluting one drop of 100x hydrogen peroxide (H2O2) (B40912-
C2, ThermoFisher) in 1mL of MilliQ water for a 1:20 dilution.
Dilute one drop of 20x Reaction buffer (B40912-C3, Invitrogen) in 1mL of MilliQ water.
Add the diluted 100x hydrogen peroxide solution to the diluted 20x reaction buffer at 1:100 dilution.
Heat the combined solution Temperature37 °C for Duration00:05:00
Add Alex Flour 488 Tyramide Reagent (B40912 Invitrogen) to the warm reaction buffer at a 1:100 dilution to produce a final Tyramide working solution.
Make this solution fresh and use it immediately.
5m
Add 100-200 µl of the Tyramide working solution to each slide and incubate at Temperature37 °C for Duration00:10:00

10m
Wash 3x Duration00:05:00 with 1x PBS and continue to coverslipping.
5m
Coverslipping
Coverslipping
Coverslip sections with Prolong gold.
Note
Different antifade reagents are available. Human brain sections labelled with up to six fluorophores and coverslipped ProLong Gold (ThermoFisher) antifade provide good protection against oxidation and bleaching.

Add a small amount of ProLong Gold (ThermoFisher) to the coverslip.
Invert the glass slide so the tissue is between the coverslip and the glass slide.
Gently push the glass slide on the coverslip, avoiding air bubbles and allowing the ProLong Gold to spread over the entire tissue section.

Video

An alternative method for coverslipping:
Gently push the coverslip on the glass slide, avoiding air bubbles and allowing the ProLong Gold to spread over the entire tissue section.

Video

Edges of cautofluorescenceoverslips can be sealed with nail polish.
Note
Avoid nail polishing over the tissue, as the nail polish generates autofluorescence.

Storage
Storage
Store sections at Temperature4 °C in slide boxes protected from light.
Note
Ideally, imaging of tissue sections should be performed as soon as possible for optimal results. However, in our hands, labelling remains present for up to five years if stored at optimal conditions.


Protocol references
The protocol detailed here was used in the following studies:

CITATION
Dieriks BV, Park TI, Fourie C, Faull RL, Dragunow M, Curtis MA (2017). α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients..

CITATION
Stevenson TJ, Murray HC, Turner C, Faull RLM, Dieriks BV, Curtis MA (2020). α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb..

CITATION
Murray HC, Low VF, Swanson ME, Dieriks BV, Turner C, Faull RL, Curtis MA (2016). Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain..

CITATION
Highet B, Dieriks BV, Murray HC, Faull RLM, Curtis MA (2020). Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease..

CITATION
Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, Faull RLM, Belluscio L, Koretsky A, Curtis MA (2020). The unfolded protein response is activated in the olfactory system in Alzheimer's disease..

CITATION
Murray HC, Swanson MEV, Dieriks BV, Turner C, Faull RLM, Curtis MA (2018). Neurochemical Characterization of PSA-NCAM(+) Cells in the Human Brain and Phenotypic Quantification in Alzheimer's Disease Entorhinal Cortex..

CITATION
Dieriks BV, Dean JM, Aronica E, Waldvogel HJ, Faull RLM, Curtis MA (2018). Differential Fatty Acid-Binding Protein Expression in Persistent Radial Glia in the Human and Sheep Subventricular Zone..

CITATION
Jansson D, Dieriks VB, Rustenhoven J, Smyth LCD, Scotter E, Aalderink M, Feng S, Johnson R, Schweder P, Mee E, Heppner P, Turner C, Curtis M, Faull R, Dragunow M (2021). Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus..

CITATION
Gardner B, Dieriks BV, Cameron S, Mendis LHS, Turner C, Faull RLM, Curtis MA (2017). Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease..

CITATION
Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M (2014). Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain..

CITATION
Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, Faull RLM, Belluscio L, Koretsky A, Curtis MA (2020). The unfolded protein response is activated in the olfactory system in Alzheimer's disease..

CITATION
Park TI, Schweder P, Lee K, Dieriks BV, Jung Y, Smyth L, Rustenhoven J, Mee E, Heppner P, Turner C, Curtis MA, Faull RLM, Montgomery JM, Dragunow M (2020). Isolation and culture of functional adult human neurons from neurosurgical brain specimens..

Citations
Dieriks BV, Park TI, Fourie C, Faull RL, Dragunow M, Curtis MA. α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients.
https://doi.org/10.1038/srep42984
Stevenson TJ, Murray HC, Turner C, Faull RLM, Dieriks BV, Curtis MA. α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb.
https://doi.org/10.1038/s41598-020-63412-x
Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, Faull RLM, Belluscio L, Koretsky A, Curtis MA. The unfolded protein response is activated in the olfactory system in Alzheimer's disease.
https://doi.org/10.1186/s40478-020-00986-7
Park TI, Schweder P, Lee K, Dieriks BV, Jung Y, Smyth L, Rustenhoven J, Mee E, Heppner P, Turner C, Curtis MA, Faull RLM, Montgomery JM, Dragunow M. Isolation and culture of functional adult human neurons from neurosurgical brain specimens.
https://doi.org/10.1093/braincomms/fcaa171
Gardner B, Dieriks BV, Cameron S, Mendis LHS, Turner C, Faull RLM, Curtis MA. Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease.
https://doi.org/10.1038/s41598-017-10659-6
Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
https://doi.org/10.1016/j.neurobiolaging.2013.11.031
Murray HC, Low VF, Swanson ME, Dieriks BV, Turner C, Faull RL, Curtis MA. Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain.
https://doi.org/10.1016/j.neuroscience.2016.06.003
Highet B, Dieriks BV, Murray HC, Faull RLM, Curtis MA. Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease.
https://doi.org/10.3389/fnagi.2020.00261
Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, Faull RLM, Belluscio L, Koretsky A, Curtis MA. The unfolded protein response is activated in the olfactory system in Alzheimer's disease.
https://doi.org/10.1186/s40478-020-00986-7
Murray HC, Swanson MEV, Dieriks BV, Turner C, Faull RLM, Curtis MA. Neurochemical Characterization of PSA-NCAM(+) Cells in the Human Brain and Phenotypic Quantification in Alzheimer's Disease Entorhinal Cortex.
https://doi.org/10.1016/j.neuroscience.2017.12.019
Dieriks BV, Dean JM, Aronica E, Waldvogel HJ, Faull RLM, Curtis MA. Differential Fatty Acid-Binding Protein Expression in Persistent Radial Glia in the Human and Sheep Subventricular Zone.
https://doi.org/10.1159/000487633
Jansson D, Dieriks VB, Rustenhoven J, Smyth LCD, Scotter E, Aalderink M, Feng S, Johnson R, Schweder P, Mee E, Heppner P, Turner C, Curtis M, Faull R, Dragunow M. Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus.
https://doi.org/10.1038/s42003-021-01787-x
Step 6
Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
https://doi.org/10.1016/j.neurobiolaging.2013.11.031